8-K//Current report
BriaCell Therapeutics Corp. 8-K
Accession 0001641172-25-019892
$BCTXCIK 0001610820operating
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:15 PM ET
Size
1.1 MB
Accession
0001641172-25-019892
Documents
- 8-Kform8-k.htmPrimary
8-K
- EX-1.1ex1-1.htm
EX-1.1
- EX-4.1ex4-1.htm
EX-4.1
- EX-4.2ex4-2.htm
EX-4.2
- EX-99.1ex99-1.htm
EX-99.1
- EX-99.2ex99-2.htm
EX-99.2
- GRAPHICex99-2_001.jpg
GRAPHIC
- EX-101.SCHbctx-20250715.xsd
XBRL SCHEMA FILE
- EX-101.DEFbctx-20250715_def.xml
XBRL DEFINITION FILE
- EX-101.LABbctx-20250715_lab.xml
XBRL LABEL FILE
- EX-101.PREbctx-20250715_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001641172-25-019892-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
BriaCell Therapeutics Corp.
CIK 0001610820
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001610820
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:15 PM ET
- Size
- 1.1 MB